CYPB Cypress Bioscience
Inactive
Company profile
Ticker
CYPB
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Bio-Techne • Enzon Pharmaceuticals • Denali Therapeutics • Allogene Therapeutics ...
Former names
Imre Corp
SEC CIK
Corporate docs
IRS number
222389839
Calendar
8 Nov 10
28 Feb 21
31 Dec 21
Financial report summary
?Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
addiction, addressing, aerosol, affiliate, agent, al, Alexza, analog, andStaccatonicotine, anniversary, apprise, attach, autism, banking, behavioral, Biotech, breakthrough, buy, capability, capable, carbetocin, carcinogenicity, Chancery, COBRA, commercializeStaccato, commercializingStaccatonicotine, complaint, consummated, core, daily, David, declared, deep, defective, deliver, delivering, description, deter, developingStaccatonicotine, developmental, developStaccatonicotine, disposal, dividend, embedded, enjoin, Exagen, expert, exploration, explore, faith, Ferring, fiduciary, formal, forStaccatonicotine, hemorrhage, holder, hormone, hostile, illusory, incurrence, inhalation, inhaled, injury, innovativeStaccatonicotine, inquiry, inStaccatonicotine, intangible, intranasal, Ireland, Junior, leave, licensor, manufactureStaccato, Marina, maximize, mimicking, monetary, monetization, movement, multidose, nicotine, Notification, occurrence, ofStaccatonicotine, oral, ordinary, orStaccatonicotine, outsource, oxytocin, par, parenteral, people, pill, pilot, plaintiff, poison, possession, postpartum, precision, preferred, proceed, produceStaccatonicotine, psychological, purportedly, put, QSR, reacquire, reclassified, recommendation, rejected, Retraining, reveal, salt, Savellafor, Savellashould, scheduled, segregated, sellingStaccatonicotine, shareholder, smoking, solve, split, Staccato, Staccatonicotine, straight, theStaccato, theStaccatodelivery, thestaccatonicotine, TheStaccatotechnology, titrate, top, toStaccatonicotine, toxicology, transdermal, true, Trust, unannounced, unpredictable, unspecified, upward, withStaccatonicotine, Worker
Removed:
activation, approvedSavellafor, autoimmune, avise, began, calling, Cellatope, CMS, commercializeSavella, commercializeSavellawill, complement, debilitating, determination, diagnose, expended, field, forSavella, forSavellaand, forSavellafor, forSavellareceived, forSavellashould, guaranteed, improving, inSavella, integrated, leader, MCV, Medicare, monitor, monitoring, ofSavella, ofSavellaand, ofSavelladuring, ofSavellafor, ofSavellaif, ofSavellain, ofSavellaor, ofSavellawhich, PG, PGandAvise, platform, secure, seeking, seizure, shipping, SM, systemic, thereforeSavellamay, toSavella, validated, validation, withSavella, withSavellaand, withSavellafor
Financial reports
10-Q
2010 Q3
Quarterly report
8 Nov 10
10-Q
2010 Q2
Quarterly report
8 Aug 10
10-Q
2010 Q1
Quarterly report
9 May 10
10-K
2009 FY
Annual report
30 Mar 10
NT 10-K
Notice of late annual filing
15 Mar 10
10-Q
2009 Q3
Quarterly report
8 Nov 09
10-Q
2009 Q2
Quarterly report
9 Aug 09
10-Q
2009 Q1
Quarterly report
10 May 09
10-K
2008 FY
Annual report
15 Mar 09
10-Q
2008 Q3
Quarterly report
9 Nov 08
Current reports
8-K
Departure of Directors or Certain Officers
21 Dec 10
8-K
Entry into a Material Definitive Agreement
15 Dec 10
8-K
Cypress Bioscience Agrees to Be Acquired by Ramius LLC and Royalty Pharma for $6.50 Per Share In Cash
14 Dec 10
8-K
Results of Operations and Financial Condition
8 Nov 10
8-K
Cypress Bioscience Announces Agreement to Sell Diagnostic Business to Exagen Diagnostics
7 Oct 10
8-K
Entry into a Material Definitive Agreement
27 Sep 10
8-K
Regulation FD Disclosure
14 Sep 10
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
30 Aug 10
8-K
Entry into a Material Definitive Agreement
25 Aug 10
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Aug 10
Registration and prospectus
15-12G
Securities registration termination
13 Jan 11
POS AM
Prospectus update (post-effective amendment)
13 Jan 11
POS AM
Prospectus update (post-effective amendment)
13 Jan 11
POS AM
Prospectus update (post-effective amendment)
13 Jan 11
POS AM
Prospectus update (post-effective amendment)
13 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Jan 11
Proxies
DFAN14A
Additional proxy materials by non-management
12 Sep 10
DEFA14A
Additional proxy soliciting materials
3 May 10
DEF 14A
Definitive proxy
29 Apr 10
DEF 14A
Definitive proxy
29 Apr 09
PRE 14A
Preliminary proxy
15 Apr 09
DEF 14A
Definitive proxy
29 Apr 08
DEF 14A
Definitive proxy
29 Apr 07
DEF 14A
Definitive proxy
30 Apr 06
DEF 14A
Definitive proxy
26 Apr 05
DEF 14A
Definitive proxy
28 Jun 04
Other
CT ORDER
Confidential treatment order
28 Dec 11
EFFECT
Notice of effectiveness
17 Jan 11
EFFECT
Notice of effectiveness
17 Jan 11
EFFECT
Notice of effectiveness
17 Jan 11
EFFECT
Notice of effectiveness
17 Jan 11
UPLOAD
Letter from SEC
12 Dec 10
UPLOAD
Letter from SEC
12 Dec 10
UPLOAD
Letter from SEC
14 Nov 10
CORRESP
Correspondence with SEC
13 Oct 10
UPLOAD
Letter from SEC
6 Oct 10
Ownership
SC 13D
CYPRESS BIOSCIENCE / RP Management ownership change
22 Dec 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius Value & Opportunity ownership change
19 Dec 10
SC 13D/A
CYPRESS BIOSCIENCE / RA CAPITAL MANAGEMENT ownership change
29 Sep 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
19 Sep 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
15 Sep 10
SC 13D
CYPRESS BIOSCIENCE / RA CAPITAL MANAGEMENT ownership change
12 Sep 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
11 Aug 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
5 Aug 10
SC 13D/A
CYPRESS BIOSCIENCE / Ramius ownership change
21 Jul 10
SC 13D
CYPRESS BIOSCIENCE / Ramius ownership change
18 Jul 10